Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: EVH stock price vs FI: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at FI's multiple
Needs FI P/S.
Implied fair value · at EVH's multiple
Needs EVH P/S.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Eight period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Evolent Health, Inc. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
FISERV, INC. · implied price per share
Bear
$41.10
Base
$57.43
Bull
$78.70
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Cigna Group
EVH vs CI
MOLINA HEALTHCARE, INC.
EVH vs MOH
Teladoc Health, Inc.
EVH vs TDOC
CLOVER HEALTH INVESTMENTS, CORP. /DE
EVH vs CLOV
UNITEDHEALTH GROUP INC
EVH vs UNH
Fidelity National Information Services, Inc.
EVH vs FIS
GLOBAL PAYMENTS INC
EVH vs GPN
JACK HENRY & ASSOCIATES INC
EVH vs JKHY
PayPal Holdings, Inc.
EVH vs PYPL
Block, Inc.
EVH vs SQ
Mastercard Incorporated
EVH vs MA
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe EVH can reverse its revenue decline and restore positive margins, then a speculative long may be warranted, but based on the current data FI is the higher-quality relative choice because it combines growth, profitability, and stronger capital efficiency.
EVH trades at a low valuation on a sales basis, with P/S of 0.3x and EV/Revenue of 0.8x, but no meaningful earnings multiple support because net income and EBITDA are negative. FI is the higher-quality FI with positive earnings and much stronger margins, so EVH's discount reflects fundamental weakness rather than clear mispricing.
Supporting Metrics
